| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.77B | 40.65B | 44.65B | 47.43B | 47.27B | 44.23B |
| Gross Profit | 10.04B | 11.07B | 12.39B | 12.57B | 12.23B | 10.14B |
| EBITDA | 2.74B | 4.10B | 5.68B | 6.05B | 6.57B | 5.44B |
| Net Income | 338.70M | 1.77B | 3.30B | 3.01B | 3.13B | 2.39B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 75.46B | 64.87B | 54.73B | 51.71B | 52.16B |
| Cash, Cash Equivalents and Short-Term Investments | 4.93B | 4.93B | 3.42B | 3.35B | 2.50B | 242.90M |
| Total Debt | 0.00 | 15.22B | 9.91B | 9.36B | 7.83B | 9.42B |
| Total Liabilities | -41.19B | 34.27B | 24.87B | 23.28B | 23.53B | 32.92B |
| Stockholders Equity | 41.19B | 40.79B | 39.56B | 31.08B | 27.98B | 19.16B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.66B | -4.55B | -1.05B | 228.10M | -492.50M |
| Operating Cash Flow | 0.00 | 3.96B | -448.80M | 2.36B | 2.06B | 568.20M |
| Investing Cash Flow | 0.00 | -5.18B | -4.49B | -446.30M | -4.58B | -769.40M |
| Financing Cash Flow | 0.00 | 1.70B | 4.54B | -1.45B | 2.48B | 249.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ₹10.43B | 40.47 | ― | ― | 38.39% | -27.69% | |
62 Neutral | ₹88.73B | -10.28 | ― | 0.55% | -17.23% | -185.73% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | ₹84.37B | -74.07 | ― | ― | -14.27% | 78.52% | |
56 Neutral | ₹101.86B | 25.29 | ― | 0.15% | -19.16% | -92.64% | |
51 Neutral | ₹94.50B | 49.76 | ― | 0.24% | 11.44% | 23.56% | |
41 Neutral | ₹720.75M | -4.51 | ― | ― | -29.38% | 73.60% |
HFCL Limited has submitted a compliance certificate to Indian stock exchanges and depositories confirming adherence to Regulation 74(5) of the SEBI (Depository and Participants) Regulations, 2018 for the quarter ended 31 December 2025. Based on confirmation from its registrar and share transfer agent, the company states that all securities received for dematerialisation during the quarter were duly processed within prescribed timelines, listed on the exchanges, appropriately confirmed to depositories, and that physical certificates were cancelled with depositories recorded as the registered owners, underscoring HFCL’s compliance with securities handling and dematerialisation norms for investors and regulators.
HFCL Limited has approved the launch of a qualified institutions placement (QIP) of its equity shares with a face value of ₹1 each, following prior approvals from its board and shareholders. At a fund-raising committee meeting held on December 22, 2025, the company authorized the opening of the QIP, set a floor price of ₹65.84 per share in line with SEBI regulations, and adopted the preliminary placement document, with the final issue price to be decided in consultation with the book running lead manager and an option to offer up to a 5% discount on the floor price. The company also confirmed that the trading window for designated persons remains closed around the issue period and that the preliminary placement document is being filed with stock exchanges and made available on its website, underscoring regulatory compliance and signaling a move to strengthen its capital base through institutional investors.
HFCL Limited has approved the launch of a qualified institutions placement (QIP) of its equity shares with a face value of ₹1 each, following prior approvals from its board and shareholders. The company’s Fund Raising Committee has authorized the opening of the issue on December 22, 2025, set a floor price of ₹65.84 per share in line with SEBI regulations, and adopted the preliminary placement document and application form. HFCL may offer up to a 5% discount to this floor price, with the final issue price to be determined in consultation with the book running lead manager, and has kept its trading window closed for designated persons and their immediate relatives until December 28, 2025 in connection with the transaction.